GURUGRAM, India, July 11, 2023 /PRNewswire/ — The Global Stem Cell Banking Market is moderately consolidated with competitive rivalry among the competitors. Some of the popular Stem Cell Bank brands like CBR, CryoCell, Life Cell, Cordlife, Vita 34, and Smart Cells compete on the basis of price, subscriptions, VAS, turnover time and inventory management.
1. North America Stem Cell Banking Market Surges: Propelled by Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicine, and Growing Clinical Studies on Cellular Therapies.
- The applications of stem cell technologies in the treatment of diseases have ultimately increased the overall adoption rate of these technologies across the region. This has led to increased investments by market players in the development of novel therapies in this area.
- With the increased availability of clinical evidence, public awareness regarding the therapeutic potential of stem cells, the market is on the rise.
- Rising investments and R&D from public and private organizations for the development & expansion of cell-based therapies are expected to drive the market.
- For instance, in January 2022, Cellino Biotech, an autonomous cell therapy manufacturing company, raised USD 80 Mn to expand access to stem cell-based therapies, healthcare spending increased by 3.4% in 2021, per the Health Care Price Index.
Interested to Know More about this Report, Request a Free Sample Report
2. The Growth of Stem Cell Banking Market in Asia Pacific: Rising Prevalence of Chronic Diseases Spurs Novel Therapeutic Technologies.
- The stem cell banking market is growing rapidly in the Asia Pacific region due to increasing awareness on therapeutic potential of stem cells for various diseases.
- For instance, the Albanese Government is investing nearly $ 7 Mn in Australia for stem cell research that will enable live stem cells to be 3D printed in order to treat damaged body parts.
- The demand for stem cell banking is driven by rising prevalence for chronic diseases such as cancer, stroke, diabetes, and obesity in Asian countries.
- Stem cell led to development of novel technologies for the treatment of diseases.
- For instance, there were over 14, 00,000 incident cases of cancer in India in the year 2022.
Visit this Link :- Request for custom report
Market Taxonomy
By Source
- Placental Stem Cells (PSCS)
- Adipose Tissue-Derived Stem Cells (ADSCS)
- Bone Marrow-Derived Stem Cells (BMSCS)
- Human Embryo-Derived Stem Cells (HESCS)
- Dental Pulp-Derived Stem Cells (DPSCS)
- Others
By Service Type
- Sample Collection and Transportation
- Sample Preservation and Storage
- Sample Analysis
- Sample Processing
Request free 30 minutes analyst call
By Application
- Personalized Banking Application
- Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery)
- Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Others)
By Cell Type
- Umbilical Cord Stem Cell
- Adult Stem Cell
- Embryonic Stem Cell
By Region
- North America (USA, Canada, and Mexico)
- Europe (France, Italy, Germany, Spain, UK, and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia Pacific)
- LAMEA (Latin America, Middle East, and Africa)
Key Players
- CBR Systems, Inc.
- Cryo-Cell International, Inc.
- ViaCord
- Sartorius AG
- StemCyte, Inc.
- Smart Cells International Limited
- Global Cord Blood Corporation
- Vita 34
- LifeCell International Pvt. Ltd
- Cordlife Group Limited
For More Insights On Market Intelligence, Refer To The Link Below: –
Global Stem Cell Banking Market
Related Report by Ken Research: –
According to Ken Research estimates, the Market Size of Global Stem Cell Banking has shown increasing trend from 2017 to 2022. However, due to COVID-19 restrictions and national & international guidelines, additional measures were taken to ensure secure stem cells collection from patients as well as donors, which resulted in decline in the overall stem cell banking market. Placental stem cells are expected to dominate the global stem cell banking market by source due to high immune tolerance which make them a promising option for transplantation and other therapeutic applications. The major market players are focusing on R&D activities to introduce new stem cell therapies in the market.
According to Ken Research estimates, the Market Size of KSA Health Tech Market has shown increasing trend from 2017 to 2022. However, COVID was the biggest driver for a significant growth rate in KSA Health Tech market where factors like emerging aging population, increased healthcare expenditure and extensive digital enablers have been driving the Health Tech Market. The number of orders placed by mobile application are expected to rise by 2027 as the market players are expected to invest in user friendly mobile applications as it convenient and easily accessible. An audio consultation with psychologists, dieticians, etc. will largely increase in future and will be preferred for quick consultations while video consultation will be preferred majorly for dermatology. Due to abundance of opportunities in the Healthcare IT solutions market both local and foreign players are expected to enter the market in KSA.
According to Ken Research estimates, the UAE Diabetes Care Services market expanded at a CAGR of ~5.9% between FY’17– FY’22P on the basis of revenue generated. The market saw rapid growth owning to the favorable government Initiatives, increase in diabetes patient and rising technological advancement. UAE Diabetes Care Services market is estimated to grow at a positive CAGR of ~6.1% between FY’22P-FY’27F. UAE Diabetes Clinics Market is anticipated to witness significant growth due to the improvements in existing services along with introduction of new improved technologies and increased privatization of health care sector. Major services provided by UAE Diabetes Health Care players are Endocrinology, antenatal/gestational and juvenile diabetes care, nutritional advice, and radiology.
According to Ken Research estimates, the Thailand Clinical Laboratory Market – which grew at a CAGR of 9.0% in the period of 2016-2021 – is expected to grow at a CAGR of 9.5% in the forecasted period of 2022F-2026F, owing to the increasing healthcare spending by aging population, expanding healthcare spending by the Government, growth in non-communicable disease and chronic diseases and increasing public awareness. The market is led by N Health; having the major share of the Clinical Laboratory Market in Thailand. Other players include Pathlab, Thonburi Clinical Labs, Bangkok Medical Labs, Medical Line Lab, Innotech Laboratories and others. Around 60.0% of medical decisions regarding early disease diagnosis, patient prognosis and treatment selection are based on laboratory diagnostic result.
Follow Us –
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research Private Limited
Ankur Gupta, Director Strategy and Growth
[email protected]
+91-9015378249
Logo: https://mma.prnewswire.com/media/1954972/Ken_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-stem-cell-market-projected-to-reach-14-bn-by-2028-ken-research-301873913.html
Featured image: Megapixl © Kentoh